Werewolf Therapeutics Stock Forecast - Price Action Indicator
| HOWL Stock | USD 1.86 0.01 0.54% |
Werewolf Stock Forecast is based on your current time horizon. Although Werewolf Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Werewolf Therapeutics' systematic risk associated with finding meaningful patterns of Werewolf Therapeutics fundamentals over time.
Werewolf |
| Check Werewolf Therapeutics Volatility | Backtest Werewolf Therapeutics | Trend Details |
Werewolf Therapeutics Trading Date Momentum
| On December 02 2024 Werewolf Therapeutics was traded for 1.96 at the closing time. The top price for the day was 2.04 and the lowest listed price was 1.89 . The trading volume for the day was 335.9 K. The trading history from December 2, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.00% . The trading price change against the current closing price is 6.50% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Werewolf Therapeutics to competition |
Other Forecasting Options for Werewolf Therapeutics
For every potential investor in Werewolf, whether a beginner or expert, Werewolf Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Werewolf Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Werewolf. Basic forecasting techniques help filter out the noise by identifying Werewolf Therapeutics' price trends.View Werewolf Therapeutics Related Equities
| Risk & Return | Correlation |
Werewolf Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Werewolf Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Werewolf Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Werewolf Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Werewolf Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Werewolf Therapeutics shares will generate the highest return on investment. By undertsting and applying Werewolf Therapeutics stock market strength indicators, traders can identify Werewolf Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 13298.22 | |||
| Daily Balance Of Power | 0.1111 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.84 | |||
| Day Typical Price | 1.84 | |||
| Price Action Indicator | 0.03 | |||
| Period Momentum Indicator | 0.01 |
Werewolf Therapeutics Risk Indicators
The analysis of Werewolf Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Werewolf Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting werewolf stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.66 | |||
| Semi Deviation | 4.66 | |||
| Standard Deviation | 7.57 | |||
| Variance | 57.3 | |||
| Downside Variance | 24.83 | |||
| Semi Variance | 21.75 | |||
| Expected Short fall | (6.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Werewolf Therapeutics to cross-verify your projections. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. If investors know Werewolf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Werewolf Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share 0.082 | Quarterly Revenue Growth (0.86) | Return On Assets (0.26) | Return On Equity (0.62) |
The market value of Werewolf Therapeutics is measured differently than its book value, which is the value of Werewolf that is recorded on the company's balance sheet. Investors also form their own opinion of Werewolf Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Werewolf Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Werewolf Therapeutics' market value can be influenced by many factors that don't directly affect Werewolf Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Werewolf Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.